Literature DB >> 22749802

Differentiation of intracranial tuberculomas and high grade gliomas using proton MR spectroscopy and diffusion MR imaging.

Juan Peng1, Yu Ouyang, Wei-Dong Fang, Tian-You Luo, Yong-Mei Li, Fa-Jin Lv, Zhi-Wei Zhang, Xin-You Li.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether proton MR spectroscopy ((1)H MRS) and diffusion-weighted (DW) imaging can be used to differentiate intracranial tuberculomas from high grade gliomas (HGGs).
MATERIALS AND METHODS: A total of 41 patients (19 with intracranial tuberculomas and 22 with HGGs) were examined in our study. (1)H MRS and DW imaging were performed at a 1.5T MR scanner before operation or treatment. Concentrations of N-acetylaspartate (NAA), creatine (Cr), choline (Cho), and lipid and lactate (LL) in the contrast-enhancing rim of each lesion were expressed as metabolite ratios and were normalized to the contralateral hemisphere. The apparent diffusion coefficient (ADC) was also calculated. The metabolite ratios and ADC values in the enhancing rim of intracranial tuberculomas and HGGs were compared using the Wilcoxon rank sum test. Diagnostic accuracy was compared using receiver operating characteristic (ROC) analysis.
RESULTS: Significant differences were found in the maximum Cho/Cr (P=0.015), Cho/NAA (P=0.001) and Cho/Cho-n ratios (P=0.002), and minimum ADC value (P<0.001) between the intracranial tuberculomas and HGGs. Diagnostic accuracy was higher by minimum ADC value than maximum Cho/Cr, Cho/NAA and Cho/Cho-n ratios (93.8% versus 75.7%, 80.8% and 78.1%).
CONCLUSION: These results suggest a promising role for (1)H MRS and DW imaging in the differentiation between the intracranial tuberculomas and HGGs.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22749802     DOI: 10.1016/j.ejrad.2012.06.005

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  9 in total

1.  Hypothalamic chiasmatic tuberculoma mimicking glioma.

Authors:  Chinmaya Dash; Raghav Singla; Kanwaljeet Garg; Vivek Tandon; Bhawani Shankar Sharma
Journal:  Childs Nerv Syst       Date:  2015-12-12       Impact factor: 1.475

2.  Central Nervous System Tuberculosis: Challenges and Advances in Diagnosis and Treatment.

Authors:  Jerome H Chin; Farrah J Mateen
Journal:  Curr Infect Dis Rep       Date:  2013-10-12       Impact factor: 3.725

Review 3.  Imaging mimics of primary malignant tumors of the central nervous system (CNS).

Authors:  Mark Daniel Anderson; Rivka R Colen; Ivo W Tremont-Lukats
Journal:  Curr Oncol Rep       Date:  2014       Impact factor: 5.075

4.  MR spectroscopy of intracranial tuberculomas: A singlet peak at 3.8 ppm as potential marker to differentiate them from malignant tumors.

Authors:  Humberto Morales; David Alfaro; Carlos Martinot; Nicolas Fayed; Mary Gaskill-Shipley
Journal:  Neuroradiol J       Date:  2015-06

5.  Headache as the leading symptom in a case of cerebral tuberculosis.

Authors:  Hans-Jonas Meyer; Dominik Schramm; Christian Kunze; Hans-Jürgen Holzhausen; Malte Kornhuber; Alexey Surov
Journal:  Neuroradiol J       Date:  2016-03-21

6.  Amide proton transfer imaging for differentiation of tuberculomas from high-grade gliomas: Preliminary experience.

Authors:  Karthik Kulanthaivelu; Shumyla Jabeen; Jitender Saini; Sanita Raju; Atchayaram Nalini; Nishanth Sadashiva; Shashank Hegde; Narayana Krishna Rolla; Indrajit Saha; Netravathi M; Seena Vengalil; Saikrishna Swaroop; Shilpa Rao
Journal:  Neuroradiol J       Date:  2021-04-07

Review 7.  Evaluation of the diagnostic performance of magnetic resonance spectroscopy in brain tumors: a systematic review and meta-analysis.

Authors:  Wenzhi Wang; Yumin Hu; Peiou Lu; Yingci Li; Yunfu Chen; Mohan Tian; Lijuan Yu
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

8.  Commentary.

Authors:  Adomas Bunevicius
Journal:  J Neurosci Rural Pract       Date:  2017 Jan-Mar

9.  Differentiation of breast tuberculosis and breast cancer using diffusion-weighted, T2-weighted and dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Dibuseng P Ramaema; Richard J Hift
Journal:  SA J Radiol       Date:  2018-10-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.